PMCCPMCCPMCC

Search tips
Search criteria 

Advanced
Logo of arthresbiomed central web sitesearch.manuscript submission.see also journal with issn 1478-6354registration.journal front page.
 
Volume 2(4);  2000
Commentaries
Physiologic role of interleukin-1 receptor antagonist
William P Arend, Cem Gabay
Arthritis Res. 2000; 2(4): 245–248. Published online 2000 May 19. doi: 10.1186/ar94
PMCID:
PMC130011
Abstract Full Text PDF–107K
Citrullination: a small change for a protein with great consequences for rheumatoid arthritis
Walther J van Venrooij, Ger J M Pruijn
Arthritis Res. 2000; 2(4): 249–251. Published online 2000 May 24. doi: 10.1186/ar95
PMCID:
PMC130012
Abstract Full Text PDF–98K
Primary Research
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
Seon Hee Kim, Christopher H Evans, Sunyoung Kim, Thomas Oligino, Steven C Ghivizzani, Paul D Robbins
Arthritis Res. 2000; 2(4): 293–302. Published online 2000 May 24.
PMCID:
PMC17812
Abstract Full Text PDF–2.7M
IgVH genes from different anatomical regions, with different histopathological patterns, of a rheumatoid arthritis patient suggest cyclic re-entry of mature synovial B-cells in the hypermutation process
Maria M Souto-Carneiro, Veit Krenn, Ralph Hermann, Achim König, Hans-Konrad Müller-Hermelink
Arthritis Res. 2000; 2(4): 303–314. Published online 2000 May 19.
PMCID:
PMC17813
Abstract Full Text PDF–3.4M
T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis
Vivianne Malmström, Johan Bäcklund, Liselotte Jansson, Jan Kihlberg, Rikard Holmdahl
Arthritis Res. 2000; 2(4): 315–326. Published online 2000 June 5.
PMCID:
PMC17814
Abstract Full Text PDF–1.0M
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
Oliver Rosen, Andreas Thiel, Gero Massenkeil, Falk Hiepe, Thomas Häupl, Hartmut Radtke, Gerd R Burmester, Erika Gromnica-Ihle, Andreas Radbruch, Renate Arnold
Arthritis Res. 2000; 2(4): 327–336. Published online 2000 June 8.
PMCID:
PMC17815
Abstract Full Text PDF–118K
Reviews
What you should know about PR3-ANCA: An introduction
Allan Wiik
Arthritis Res. 2000; 2(4): 252–254. Published online 2000 June 12. doi: 10.1186/ar96
PMCID:
PMC130013
Abstract Full Text PDF–169K
What you should know about PR3-ANCA: Structural aspects of antibodies to proteinase 3 (PR3)
Elisabeth Peen, Williams Ralph C, Jr
Arthritis Res. 2000; 2(4): 255–259. Published online 2000 June 12. doi: 10.1186/ar97
PMCID:
PMC130014
Abstract Full Text PDF–571K
What you should know about PR3-ANCA: Evidence for the role of T cells in the pathogenesis of systemic vasculitis
Abigail R Clayton, Caroline OS Savage
Arthritis Res. 2000; 2(4): 260–262. Published online 2000 June 12. doi: 10.1186/ar98
PMCID:
PMC130015
Abstract Full Text PDF–97K
What you should know about PR3-ANCA: Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA
Ulrich Specks
Arthritis Res. 2000; 2(4): 263–267. Published online 2000 June 12. doi: 10.1186/ar99
PMCID:
PMC130016
Abstract Full Text PDF–139K
Immune ablation and stem-cell therapy in autoimmune disease: Introduction
Ferdinand C Breedveld
Arthritis Res. 2000; 2(4): 268–269. Published online 2000 May 24. doi: 10.1186/ar100
PMCID:
PMC130007
Full Text PDF–75K
Immune ablation and stem-cell therapy in autoimmune disease: Clinical experience
Alan Tyndall, Alois Gratwohl
Arthritis Res. 2000; 2(4): 276–280. Published online 2000 May 26. doi: 10.1186/ar102
PMCID:
PMC130009
Abstract Full Text PDF–110K
Immune ablation and stem-cell therapy in autoimmune disease: Experimental basis for autologous stem-cell transplantation
Dirk W van Bekkum
Arthritis Res. 2000; 2(4): 281–284. Published online 2000 June 2. doi: 10.1186/ar103
PMCID:
PMC130010
Abstract Full Text PDF–99K
Articles from Arthritis Research are provided here courtesy of
BioMed Central